- Home
- FBRX vs SMBK Comparison
FBRX vs SMBK Comparison
Compare FBRX & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FBRX | SMBK |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 899.4M | 777.3M |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FBRX | SMBK |
|---|---|---|
| Price | $76.52 | $52.81 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $67.00 | $43.17 |
| AVG Volume (30 Days) | ★ 1.9M | 109.2K |
| Earning Date | 05-14-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ 61.30 | 39.25 |
| EPS | N/A | ★ 0.81 |
| Revenue | ★ $36,000.00 | N/A |
| Revenue This Year | N/A | $17.59 |
| Revenue Next Year | N/A | $10.30 |
| P/E Ratio | ★ N/A | $65.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.25 | $32.64 |
| 52 Week High | $76.68 | $53.32 |
Technical Indicators
Market Signals| Indicator | FBRX | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 85.36 | 78.31 |
| Support Level | $24.72 | $40.28 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 4.60 | 1.58 |
| MACD | 3.29 | 0.44 |
| Stochastic Oscillator | 99.54 | 95.82 |
Price Performance
Historical ComparisonAbout FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.
About SMBK SmartFinancial Inc.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.